QR Kodea

Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in Belgium

ABSTRACT Background In the United States, beta‐lactam allergy labels (BLAL) are documented in 9%–16% of hospitalized patients and associated with worse clinical outcomes such as increased mortality, length of hospital stay (LOS), intensive care unit (ICU) admission, and use of alternative antibiotic...

Deskribapen osoa

Gorde:
Egile Nagusiak: Liesbeth Gilissen, Greet Van De Sijpe, Annouschka Laenen, Peter Declercq, Dries Wets, Ileana Ghiordanescu, Anca Mirela Chiriac, Willy E. Peetermans, Paul De Munter, Isabel Spriet, Rik Schrijvers
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley 2026-04-01
Saila:Clinical and Translational Allergy
Gaiak:
antimicrobial stewardship
beta‐lactams
delabeling
drug allergy
penicillin allergy
Sarrera elektronikoa:https://doi.org/10.1002/clt2.70166
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak